1
/
of
1
Elabscience
SKU:PKSH033996
Recombinant Human TACI/TNFRSF13B/CD267 (C-Fc)
Recombinant Human TACI/TNFRSF13B/CD267 (C-Fc)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human TACI/TNFRSF13B/CD267 (C-FC), a cutting-edge product that revolutionizes the field of immunology. This meticulously engineered recombinant protein showcases the fusion of TACI, TNFRSF13B, and CD267, offering an unparalleled solution for researchers and scientists alike.
Crafted with utmost precision, this product embodies the epitome of scientific advancement. TACI, a transmembrane receptor, is fused with TNFRSF13B and CD267, resulting in a multifaceted protein with enhanced functionality. This fusion protein exhibits remarkable binding affinity towards its ligands, thereby facilitating a comprehensive understanding of the intricate mechanisms underlying immune responses.
The Recombinant Human TACI/TNFRSF13B/CD267 (C-FC) boasts exceptional purity and stability, ensuring consistent and reliable results in various experimental settings. Its high bioactivity enables researchers to delve into the complexities of immune regulation, paving the way for groundbreaking discoveries and advancements in the field.
This product's versatility extends beyond its remarkable binding capabilities. Its compatibility with a wide range of applications, including ELISA, Western blotting, and functional assays, empowers researchers to explore diverse avenues of immunological research. With its robust performance and adaptability, this recombinant protein serves as an indispensable tool for unraveling the intricacies of immune signaling pathways.
Furthermore, the Recombinant Human TACI/TNFRSF13B/CD267 (C-FC) is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures. This ensures the utmost purity, consistency, and reliability of each batch, guaranteeing reproducible results and minimizing experimental variability.
In summary, the Recombinant Human TACI/TNFRSF13B/CD267 (C-FC) represents a groundbreaking advancement in immunological research. Its fusion of TACI, TNFRSF13B, and CD267 offers unparalleled binding affinity and functionality, enabling researchers to unravel the complexities of immune responses. With its exceptional purity, stability, and compatibility with various applications, this recombinant protein is an indispensable asset for scientists and researchers striving to push the boundaries of immunology.
Crafted with utmost precision, this product embodies the epitome of scientific advancement. TACI, a transmembrane receptor, is fused with TNFRSF13B and CD267, resulting in a multifaceted protein with enhanced functionality. This fusion protein exhibits remarkable binding affinity towards its ligands, thereby facilitating a comprehensive understanding of the intricate mechanisms underlying immune responses.
The Recombinant Human TACI/TNFRSF13B/CD267 (C-FC) boasts exceptional purity and stability, ensuring consistent and reliable results in various experimental settings. Its high bioactivity enables researchers to delve into the complexities of immune regulation, paving the way for groundbreaking discoveries and advancements in the field.
This product's versatility extends beyond its remarkable binding capabilities. Its compatibility with a wide range of applications, including ELISA, Western blotting, and functional assays, empowers researchers to explore diverse avenues of immunological research. With its robust performance and adaptability, this recombinant protein serves as an indispensable tool for unraveling the intricacies of immune signaling pathways.
Furthermore, the Recombinant Human TACI/TNFRSF13B/CD267 (C-FC) is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures. This ensures the utmost purity, consistency, and reliability of each batch, guaranteeing reproducible results and minimizing experimental variability.
In summary, the Recombinant Human TACI/TNFRSF13B/CD267 (C-FC) represents a groundbreaking advancement in immunological research. Its fusion of TACI, TNFRSF13B, and CD267 offers unparalleled binding affinity and functionality, enabling researchers to unravel the complexities of immune responses. With its exceptional purity, stability, and compatibility with various applications, this recombinant protein is an indispensable asset for scientists and researchers striving to push the boundaries of immunology.
Share
